Government to boost SK Biopharm’s epilepsy drug development

Published: 2012-02-29 06:57:00

Updated: 2012-02-29 06:57:00

The government has recently unveiled its plan to support SK Biopharmaceuticals’ new epilepsy drug as part of its efforts to nurture blockbuster drugs, targeting the international market.

The company has since 2006 been developing a medicine for intractable epilepsy, a set of chronic neurologic...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK